Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

754 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease.
Hamilton VM, Norris C, Bunin N, Goldwein JW, Bunin GR, Lange B, Meadows AT. Hamilton VM, et al. J Pediatr Hematol Oncol. 2001 Feb;23(2):84-8. doi: 10.1097/00043426-200102000-00003. J Pediatr Hematol Oncol. 2001. PMID: 11216711 Clinical Trial.
Immunization of leukemic children with Haemophilus conjugate vaccine.
Lange B, Jakacki R, Nasab AH, Luery N, McVerry PH. Lange B, et al. Pediatr Infect Dis J. 1989 Dec;8(12):883-4. doi: 10.1097/00006454-198912000-00011. Pediatr Infect Dis J. 1989. PMID: 2626288 Clinical Trial. No abstract available.
Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia.
Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, Womer RB, Lange B, Rovera G. Wasserman R, et al. J Clin Oncol. 1992 Dec;10(12):1879-88. doi: 10.1200/JCO.1992.10.12.1879. J Clin Oncol. 1992. PMID: 1453203
PURPOSE: More than 95% of children with B-lineage acute lymphoblastic leukemia (ALL) achieve a clinical remission after the induction phase of chemotherapy (first 28 days) as evaluated by morphologic criteria. ...PATIENTS AND METHODS: All children diagnosed with B-l …
PURPOSE: More than 95% of children with B-lineage acute lymphoblastic leukemia (ALL) achieve a clinical remission after the induction …
Bone marrow transplantation for childhood Ki-1 lymphoma.
Chakravarti V, Kamani NR, Bayever E, Lange B, Herzog P, Sanders JE, August CS. Chakravarti V, et al. J Clin Oncol. 1990 Apr;8(4):657-60. doi: 10.1200/JCO.1990.8.4.657. J Clin Oncol. 1990. PMID: 2156024
Chromosome 7 abnormalities in children with Down syndrome and preleukemia.
Bunin N, Nowell PC, Belasco J, Shah N, Willoughby M, Farber PA, Lange B. Bunin N, et al. Cancer Genet Cytogenet. 1991 Jul 1;54(1):119-26. doi: 10.1016/0165-4608(91)90039-w. Cancer Genet Cytogenet. 1991. PMID: 1829646
Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia.
Ito Y, Wasserman R, Galili N, Reichard BA, Shane S, Lange B, Rovera G. Ito Y, et al. J Clin Oncol. 1993 Mar;11(3):546-53. doi: 10.1200/JCO.1993.11.3.546. J Clin Oncol. 1993. PMID: 8445430
PURPOSE: We have investigated whether the extent of residual leukemia in the marrows obtained at the completion of chemotherapy can predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia (ALL). ...
PURPOSE: We have investigated whether the extent of residual leukemia in the marrows obtained at the completion of chemotherapy can predict …
Hypofractionated moderate dose radiation, intrathecal chemotherapy, and repetitive reinduction/reconsolidation systemic therapy for central nervous system relapse of acute lymphoblastic leukemia in children.
Belasco JB, Goldwein JW, Simms S, Griffin G, D'Angio G, Lange B. Belasco JB, et al. Med Pediatr Oncol. 2000 Feb;34(2):125-31. doi: 10.1002/(sici)1096-911x(200002)34:2<125::aid-mpo10>3.0.co;2-k. Med Pediatr Oncol. 2000. PMID: 10657874
A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML).
Leahey A, Kelly K, Rorke LB, Lange B. Leahey A, et al. J Pediatr Hematol Oncol. 1997 Jul-Aug;19(4):304-8. doi: 10.1097/00043426-199707000-00007. J Pediatr Hematol Oncol. 1997. PMID: 9256828 Clinical Trial.
754 results
Jump to page
Feedback